Page last updated: 2024-09-05

dabigatran and Degenerative Diseases, Central Nervous System

dabigatran has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callejas, S; Ceron, C; Cortes-Canteli, M; Fernandez-Nueda, I; Fuster, V; Ibanez, B; Jno-Charles, OC; Kruyer, A; Marcos-Diaz, A; Norris, EH; Richards, AT; Rodriguez, I; Ruiz-Cabello, J; Sanchez-Gonzalez, J; Strickland, S1

Other Studies

1 other study(ies) available for dabigatran and Degenerative Diseases, Central Nervous System

ArticleYear
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model.
    Journal of the American College of Cardiology, 2019, 10-15, Volume: 74, Issue:15

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Anticoagulants; Blood-Brain Barrier; Cerebral Cortex; Dabigatran; Disease Models, Animal; Female; Fibrin; Hemostasis; Hippocampus; Maze Learning; Memory; Mice; Mice, Transgenic; Neurodegenerative Diseases; Perfusion; Thrombosis

2019